Pharma Promotion / Incidents by company / Mylan / Viatris
Mylan / Viatris
4 incidents / jurisdictions: United States / sum of amounts reported: USD 930.0 m
| Date | Jurisdiction | Outcome | What happened (source) | Damages / settlement / fine |
|---|---|---|---|---|
| 2026-07-30 | United States | Warning letter / order | Viatris runs into FDA roadblock after advertising on-the-go use of cystic fibrosis inhaler Fierce Pharma | — |
| 2026-07-21 | United States | Warning letter / order | FDA slaps Sanofi, Viatris with Untitled Letters over promotional emails, TV ad Medical Marketing and Media | — |
| 2017-08-17 | United States | Settlement | Mylan Agrees to Pay $465 Million to Resolve False Claims Act Liability U.S. Department of Justice + 1 more reports | $465 Million |
| 2006 | United States | Settlement | 2006 | Mylan | $465 million | Misclassification under the Medicaid Drug Rebate Program | EpiPen ( epinephrine ) | False Claims Act Wikipedia: List of largest pharmaceutical settlements | $465 million |
Amounts are extracted mechanically from headlines and summaries and kept only when Jev confirms they are paid by the company. The same case reported by several articles may be counted more than once, so totals are indicative. Check the sources.